Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue

Shock

Volumn 13, Issue 5, 2000, Pages 386-391

  Bahrami, Soheyl ^a   Fitzal, Florian ^a   Peichl, Gerd ^a   Gasser, Harald ^a   Fuerst, Walter ^a   Banerjee, Asmita ^a   Strohmaier, Wolfgang ^a   Redl, Heinz ^a   Werner Felmayer, Gabriela ^b   Werner, Ernst R ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cytokines; Endotoxic shock; Nitric oxide; Nitric oxide synthase; Survival rate; Tetrahydrobiopterin

Indexed keywords

4 AMINO TETRAHYDROBIOPTERIN; 4-AMINO-TETRAHYDROBIOPTERIN; BIOPTERIN; DRUG DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2 PROTEIN, RAT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; CELL LINE; COMPARATIVE STUDY; DRUG ANTAGONISM; ENDOTOXEMIA; ENZYMOLOGY; IMMUNOLOGY; MALE; METABOLISM; MOUSE; RAT; SEPTIC SHOCK; SPRAGUE DAWLEY RAT;

ANIMALS; BIOPTERIN; CELL LINE; ENDOTOXEMIA; ENZYME INHIBITORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034181284     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200005000-00007     Document Type: Article

References (44)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
2. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330, 1995.
3. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666, 1988.
4. Kubes P, Granger N: Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611-H615, 1992.
5. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P: Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 265:H862-H867, 1993.
6. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90:9813-9817, 1993.
7. Johnston B, Kanwar S, Kubes P: Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am J Physiol 271:H614-H621, 1996.
8. Sheffler LA, Wink DA, Melillo G, Cox GW: Exogenous nitric oxide regulates IFN gamma plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 155:886-894, 1995.
9. Palmer RMJ, Bridge L, Foxwell NA, Moncada S: The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105:11-12, 1992.
10. Boughton-Smith NK, Laszlo F, Whittle BJR, Moncada S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110:1189-1195, 1993.
11. Szabo C: Inducible nitric oxide synthase: its role in inflammation, sepsis and shock. Shock 6:25-26, 1996.
12. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996.
13. Szabo C: The pathophyisological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6:79-88, 1996.
14. Lipton SA, Chol Y-B, Pan Z-H, Lei SZ, Chen HV, Sucher NJ, Loscalco J, Singel DJ, Stamler JS: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature 364:626-632, 1993.
15. Yao Y-M, Bahrami S, Leichtfried G, Redl H, Schlag G: Significance of NO in hemorrhagic-induced hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 270:H1616-H1623, 1996.
16. Rees DD, Palmer RMJ, Shulz R, Moncada S: Characterisation of three inhibitors of endothelial nitric oxide in vitro and in vivo. Br J Pharmacol 101:746-752, 1990.
17. Vallance P, Moncada S: Role of endogenous nitric oxide in septic shock. New Horiz 1:77-86, 1993.
18. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
19. Gundersen Y, Corso CO, Leiderer R, Dörger M, Lilleaasen P, Aasen AO, Messmer K: Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: effects on hepatic morphology and function. Shock 8:368-372, 1997.
20. Laszlo F, Whittle BJR, Moncada S: Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol 113:1131-1136, 1994.
21. Mulder MF, van Lambalgen AA, Huisman E, Visser JJ, van den Bos GC, Thijs LG: Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 266:H1558-H1564, 1994.
22. Mayer B, Hemmens B: Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22:477-481, 1997.
23. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H: Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med 172:1599-1607, 1990.
24. Gross SS, Levi R: Tetrahydrobiopterin synthesis - an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 367:25772-25729, 1992.
25. Werner ER, Werner-Felmayer G, Mayer B: Tetrahydrobiopterin, cytokines and NO synthesis. Proc Soc Exp Biol Med 219:171-182, 1998.
26. Werner-Felmayer G, Prast H, Werner ER, Philippu A, Wachter H: Induction of GTP cyclohydrolase I by bacterial lipopolysaccharide in the rat. FEBS Lett 322:223-226, 1993.
27. Werner ER, Pitters E, Schmidt K, Wachter H, Werner-Felmayer G, Mayer B: Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J 320:193-196, 1996.
28. Pfeiffer S, Gorren ACF, Pitters E, Schmidt K, Werner ER, Mayer B: Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-amino tetrahydrobiopterin. Biochem J 328:349-352, 1997.
29. Mayer B, Wu C, Gorren ACF, Pfeiffer S, Schmidt K, Clark P, Stuehr DJ, Werner ER: Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino tetrahydrobiopterin. Biochemistry 36:8422-8427, 1997.
30. Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G: Similar cytokine but different coagulation responses to lipopolysaccharide in D-galactosamine-sensitized versus nonsensitized rats. Infect Immun 62:99-105, 1994.
31. Nava E, Palmer RMJ, Moncada S: The role of nitric oxide in endotoxic shock: effects of NG-monomethyl-L-arginine. J Cardiovasc Pharmacol 20:S132-S134, 1992.
32. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal Biochem 126:131-138, 1982.
33. Griess P: Bemerkungen zu der Abhandlung der HH Weselsky und Benedikt "über einige Azoverbindungen." Ber Dtsch Chem Ges 1:426-428, 1897.
34. Salter M, Knowles RG, Moncada S: Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett 291:145-149, 1991.
35. Von Asmuth EJ, Maessen JG, Van der Linder CJ, Buurman WA: Tumor necrosis factor-alpha (TNF) and interleukin 6 in a zymosan induced shock model. Scand J Immunol 32:313-319, 1990.
36. Tani Y, Ohno T: Analysis of 6R- and 6S-tetrahydrobiopterin and other pterins by reversed-phase ion-pair liquid chromatography with fluorimetric detection by post-column sodium nitrite oxidation. J Chromatogr 617: 249-255, 1993.
37. Schmidt K, Werner-Felmayer G, Mayer B, Werner ER: Preferential inhibiton of inducible nitric oxide synthase by the 4-amino analogue of tetrahydrobiopterin in cultured cells. Eur J Biochem 259:25-31, 1999.
38. Tiao G, Rafferty J, Ogle C, Fischer JE, Hasselgren PO: Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116:332-338, 1994.
39. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L: Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 15:2940-2946, 1997.
40. Joshi PC, Grogan JB, Thomae KR: Effect of aminoguanidine on in vivo expression of cytokines and inducible nitric oxide synthase in the lungs of endotoxemic rats. Res Commun Mol Pathol Pharmacol 91:339-346, 1996.
41. Aono K, Isobe K, Kiuchi K, Fan ZH, Ito M, Takeuchi A, Miyachi M, Nakashima I, Nimura Y: In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines. J Cell Biochem 65:349-358, 1997.
42. Harbrecht B, Billiar TR, Stadler J, Demetris AJ, Ochoa AB, Curran RD, Simmons RL: Nitric oxide serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 20:1568-1574, 1992.
43. Diefenbach A, Schindler H, Dornhauser N, Lorenz E, Laskay T, Macmicking J, Röllinghoff M, Bogdan C: Type I interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77-87, 1998.
44. Gorren AC, List BM, Schrammel A, Pitters E, Hemmens B, Werner ER, Schmidt K, Mayer B: Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. Biochemistry 35:16735-16745, 1996.